With the responsibility of keeping Ohio Northern students at the forefront of pharmacy education, an anonymous faculty member has agreed to participate in a direct-to-consumer (DTC) genetic screening.
Read excerpts from his blog:
“As I have talked about ‘poor metabolizers’ and ‘extensive metabolizers’ related to specific drugs and pharmacokinetics in class for years, I felt that this needed to be placed in the context of the bigger picture. I sent my DNA to arguably the most commercial of the direct-to-consumer (DTC) personal genomic companies (23andMe), so I could delve into this new world of genetic information. I specifically was looking at this information to see the pharmacogenetic side of things. I wanted to study my genetic makeup in order to predict how I would respond to certain drugs and to understand how certain drugs should be prescribed for me. My DNA is my DNA, so why not use it? Most importantly, for our students (and myself) at the Raabe College of Pharmacy, I understood it could be a great learning experience.”
“Personalized medicine is here. It is in its infancy, and we all will watch it grow. This blog is meant to help move everyone, including myself, along the learning curve. As I learn what my genome is telling me – and what it is not telling me, I will share it with you. I will have comments and, I am sure, many questions. I sincerely hope you will contemplate the information, formulate your thoughts and contribute to this educational experience. So, please join me on this journey as I uncover my genetic predisposition!”
“The pieces of my personal ‘puzzle.’ I am a 51-year old-white male. I am 5 feet 8 inches tall and weigh 194 lbs. Here I list the test performed, the trait as I express it and a comment where noted. I am interested to see what my DNA says about these traits.”